BioCina Pty Ltd. has announced an exclusive agreement to utilise CelluTx’s recombination-based plasmid system (RBPS) technology with its CDMO clients. The RBPS technology is a novel method for minicircle DNA (mcDNA) production, which involves site-specific recombination within a bacterial host. This
BioCina Pty Ltd., a global biologics Contract Development and Manufacturing Organization (CDMO), has announced the acquisition of exclusive rights to utilize CelluTx’s Recombination Based Plasmid System (RBPS) technology. This partnership is set to enhance minicircle DNA (mcDNA) production, a crucial
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
